Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life

医学 血压 内科学 心脏病学 指南 队列 冲程(发动机) 冠状动脉疾病 心力衰竭 舒张期 前瞻性队列研究 病理 机械工程 工程类
作者
Yuichiro Yano,Jared P. Reis,Laura A. Colangelo,Daichi Shimbo,Anthony J. Viera,Norrina B. Allen,Samuel S. Gidding,Adam P. Bress,Philip Greenland,Paul Muntner,Donald M. Lloyd‐Jones
出处
期刊:JAMA [American Medical Association]
卷期号:320 (17): 1774-1774 被引量:273
标识
DOI:10.1001/jama.2018.13551
摘要

Little is known regarding the association between level of blood pressure (BP) in young adulthood and cardiovascular disease (CVD) events by middle age.To assess whether young adults who developed hypertension, defined by the 2017 American College of Cardiology (ACC)/American Heart Association (AHA) BP guideline, before age 40 years have higher risk for CVD events compared with those who maintained normal BP.Analyses were conducted in the prospective cohort Coronary Artery Risk Development in Young Adults (CARDIA) study, started in March 1985. CARDIA enrolled 5115 African American and white participants aged 18 to 30 years from 4 US field centers (Birmingham, Alabama; Chicago, Illinois; Minneapolis, Minnesota; and Oakland, California). Outcomes were available through August 2015.Using the highest BP measured from the first examination to the examination closest to, but not after, age 40 years, each participant was categorized as having normal BP (untreated systolic BP [SBP] <120 mm Hg and diastolic BP [DBP] <80 mm Hg; n = 2574); elevated BP (untreated SBP 120-129 mm Hg and DBP <80 mm Hg; n = 445); stage 1 hypertension (untreated SBP 130-139 mm Hg or DBP 80-89 mm Hg; n = 1194); or stage 2 hypertension (SBP ≥140 mm Hg, DBP ≥90 mm Hg, or taking antihypertensive medication; n = 638).CVD events: fatal and nonfatal coronary heart disease (CHD), heart failure, stroke, transient ischemic attack, or intervention for peripheral artery disease (PAD).The final cohort included 4851 adults (mean age when follow-up for outcomes began, 35.7 years [SD, 3.6]; 2657 women [55%]; 2441 African American [50%]; 206 taking antihypertensive medication [4%]). Over a median follow-up of 18.8 years, 228 incident CVD events occurred (CHD, 109; stroke, 63; heart failure, 48; PAD, 8). CVD incidence rates for normal BP, elevated BP, stage 1 hypertension, and stage 2 hypertension were 1.37 (95% CI, 1.07-1.75), 2.74 (95% CI, 1.78-4.20), 3.15 (95% CI, 2.47-4.02), and 8.04 (95% CI, 6.45-10.03) per 1000 person-years, respectively. After multivariable adjustment, hazard ratios for CVD events for elevated BP, stage 1 hypertension, and stage 2 hypertension vs normal BP were 1.67 (95% CI, 1.01-2.77), 1.75 (95% CI, 1.22-2.53), and 3.49 (95% CI, 2.42-5.05), respectively.Among young adults, those with elevated blood pressure, stage 1 hypertension, and stage 2 hypertension before age 40 years, as defined by the blood pressure classification in the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guidelines, had significantly higher risk for subsequent cardiovascular disease events compared with those with normal blood pressure before age 40 years. The ACC/AHA blood pressure classification system may help identify young adults at higher risk for cardiovascular disease events.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
俭朴夜雪发布了新的文献求助10
刚刚
Hello应助橙橙梨梨茶采纳,获得10
1秒前
认真的rain发布了新的文献求助50
2秒前
深情的鑫鹏完成签到,获得积分10
2秒前
寒涛先生发布了新的文献求助10
3秒前
空心发布了新的文献求助30
3秒前
希望天下0贩的0应助星星采纳,获得10
4秒前
krkr完成签到,获得积分10
4秒前
4秒前
4秒前
科研通AI5应助111111111采纳,获得10
5秒前
5秒前
粗犷的书包完成签到,获得积分10
6秒前
Jasper应助shanbaibai采纳,获得10
6秒前
6秒前
Laus发布了新的文献求助10
9秒前
9秒前
cheung发布了新的文献求助10
9秒前
害羞向日葵完成签到 ,获得积分10
10秒前
ppp完成签到,获得积分10
11秒前
唠叨的白萱完成签到,获得积分10
12秒前
傲娇的凡旋完成签到,获得积分10
12秒前
fusheng完成签到 ,获得积分10
13秒前
13秒前
兔子完成签到,获得积分20
14秒前
Zzzzzzzzzzz完成签到,获得积分20
14秒前
14秒前
15秒前
16秒前
17秒前
谭谨川发布了新的文献求助10
17秒前
cheung完成签到,获得积分10
17秒前
乌日汗完成签到,获得积分10
18秒前
18秒前
18秒前
公茂源完成签到 ,获得积分10
19秒前
共享精神应助spurs17采纳,获得30
20秒前
BONBON发布了新的文献求助10
21秒前
liuqian发布了新的文献求助10
21秒前
浮生完成签到 ,获得积分10
21秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527928
求助须知:如何正确求助?哪些是违规求助? 3108040
关于积分的说明 9287614
捐赠科研通 2805836
什么是DOI,文献DOI怎么找? 1540070
邀请新用户注册赠送积分活动 716904
科研通“疑难数据库(出版商)”最低求助积分说明 709808